- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Padeliporfin is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- ATC classification
- L01XD07 Padeliporfin · Cancer medicines (antineoplastics), subgroup L01X, subgroup L01XD
- US FDA first approval
- Not recorded
- EU status
- Authorised
- Orphan designation
- No
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Identifiers
- UNII EEO29FZT86CAS 759457-82-4DrugBank DB15575Q27277134
All presentations
No presentations of Padeliporfin are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Padeliporfin available for export from India?
No presentation of Padeliporfin is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Padeliporfin authorised in the European Union?
Yes. Padeliporfin has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Padeliporfin need cold chain shipping?
No listed presentation of Padeliporfin is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Padeliporfin in?
Padeliporfin is classified under ATC code L01XD07 (Padeliporfin).
References
- Tookad: European public assessment report (EPAR). European Medicines Agency. Retrieved 20 October 2026
Request Padeliporfin for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.